Fusion event
HBV-chr9 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGA| |CCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAA
End
90879933/88265018 (Hg38)
Nearest miRNA
hsa-mir-101-2/Upstream/4295161; hsa-let-7a-1/Downstream/480818;
Upstream sequence
gttgcagagagccaagatcacaccactgcactccagcctgggcaacagagcgagactccatctcaaaaaaaaaaaaaaaaaaaaaaaattaaaaaatggt
Downstream sequence
CTGCTGCAGCCCCATGCTCTGTGCCCTCCCTGACTCTTGGGGCAGCTGTAAAGCTGGGATCTGCAGCTGCACCCTGGCCTCTCAGGAGCCACCATGTAGC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.